XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 10.26%3.39B | 10.35%832.17M | 9.02%916.27M | 8.67%891.92M | 13.73%748.35M | 14.00%3.07B | 14.02%754.09M | 15.17%840.43M | 14.94%820.75M | 11.40%658.02M |
Operating revenue | 10.26%3.39B | 10.75%848.7M | 8.86%909.88M | 8.57%886.65M | 13.73%748.35M | 14.00%3.07B | 15.87%766.35M | 14.55%835.85M | 14.37%816.69M | 11.40%658.02M |
Cost of revenue | 9.07%1.6B | 9.49%405.46M | 8.59%421.89M | 6.79%410.29M | 11.85%365.56M | 12.34%1.47B | 12.87%370.31M | 11.60%388.53M | 14.08%384.19M | 10.65%326.84M |
Gross profit | 11.36%1.79B | 11.19%426.71M | 9.40%494.38M | 10.33%481.64M | 15.59%382.79M | 15.57%1.6B | 15.14%383.78M | 18.44%451.89M | 15.72%436.56M | 12.15%331.17M |
Operating expense | 11.16%1.13B | 12.82%276.08M | 12.24%302.58M | 6.21%299.26M | 14.36%250.37M | 13.53%1.01B | 14.68%244.71M | 14.16%269.57M | 16.15%281.77M | 8.43%218.93M |
Selling and administrative expenses | 10.91%1.02B | 12.34%245.55M | 12.25%274.92M | 6.35%271.55M | 13.55%223.06M | 14.02%915.23M | 14.82%218.57M | 14.67%244.91M | 16.07%255.33M | 9.87%196.43M |
Depreciation amortization depletion | 13.50%113.22M | 16.80%30.54M | 12.15%27.66M | 4.81%27.71M | 21.37%27.31M | 9.23%99.75M | 13.50%26.14M | 9.34%24.67M | 16.96%26.44M | -2.70%22.5M |
-Depreciation and amortization | 13.50%113.22M | 16.80%30.54M | 12.15%27.66M | 4.81%27.71M | 21.37%27.31M | 9.23%99.75M | 13.50%26.14M | 9.34%24.67M | 16.96%26.44M | -2.70%22.5M |
Operating profit | 11.69%657.22M | 8.31%150.63M | 5.20%191.8M | 17.82%182.38M | 17.98%132.42M | 19.26%588.42M | 15.97%139.07M | 25.39%182.32M | 14.93%154.79M | 20.18%112.24M |
Net non-operating interest income expense | -45.25%-27.68M | 39.13%-5.03M | -28.90%-7.15M | -62.49%-7.78M | -1,561.29%-7.73M | -622.33%-19.06M | -2,300.58%-8.26M | -555.67%-5.55M | -443.75%-4.79M | 18.13%-465K |
Non-operating interest expense | 45.25%27.68M | -39.13%5.03M | 28.90%7.15M | 62.49%7.78M | 1,561.29%7.73M | 622.33%19.06M | 2,300.58%8.26M | 555.67%5.55M | 443.75%4.79M | -18.13%465K |
Other net income (expense) | -95.96%683K | -101.58%-250K | 112.38%582K | -59.57%412K | -101.29%-61K | 106.81%16.89M | 429.20%15.86M | -337.53%-4.7M | -46.68%1.02M | 268.57%4.71M |
Special income (charges) | --0 | --0 | --0 | ---- | ---- | ---5.2M | --0 | ---5.2M | ---- | ---- |
-Less:Restructuring and merger&acquisition | --0 | --0 | --0 | ---- | ---- | --5.2M | --0 | --5.2M | ---- | ---- |
Other non- operating income (expenses) | -96.91%683K | -101.58%-250K | 18.05%582K | -59.57%412K | -101.29%-61K | 170.43%22.09M | 429.20%15.86M | -75.10%493K | -46.68%1.02M | 268.57%4.71M |
Income before tax | 7.50%630.23M | -0.90%145.35M | 7.65%185.23M | 15.89%175.01M | 7.00%124.64M | 17.51%586.26M | 19.67%146.68M | 17.42%172.07M | 11.29%151.02M | 23.79%116.49M |
Income tax | 8.30%163.85M | 4.76%39.68M | 9.08%48.32M | 11.59%45.62M | 7.04%30.24M | 16.10%151.3M | -1.12%37.87M | 17.82%44.29M | 19.92%40.88M | 38.95%28.26M |
Net income | 7.22%466.38M | -2.87%105.68M | 7.15%136.91M | 17.48%129.4M | 6.98%94.39M | 18.00%434.96M | 29.11%108.8M | 17.29%127.78M | 8.39%110.14M | 19.61%88.23M |
Net income continuous Operations | 7.22%466.38M | -2.87%105.68M | 7.15%136.91M | 17.48%129.4M | 6.98%94.39M | 18.00%434.96M | 29.11%108.8M | 17.29%127.78M | 8.39%110.14M | 19.61%88.23M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 7.22%466.38M | -2.87%105.68M | 7.15%136.91M | 17.48%129.4M | 6.98%94.39M | 18.00%434.96M | 29.11%108.8M | 17.29%127.78M | 8.39%110.14M | 19.61%88.23M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 7.22%466.38M | -2.87%105.68M | 7.15%136.91M | 17.48%129.4M | 6.98%94.39M | 18.00%434.96M | 29.11%108.8M | 17.29%127.78M | 8.39%110.14M | 19.61%88.23M |
Basic earnings per share | 7.87%0.96 | 0.00%0.22 | 7.69%0.28 | 22.73%0.27 | 5.56%0.19 | 18.67%0.89 | 29.41%0.22 | 18.18%0.26 | 4.76%0.22 | 20.00%0.18 |
Diluted earnings per share | 7.87%0.96 | 0.00%0.22 | 7.69%0.28 | 22.73%0.27 | 5.56%0.19 | 18.67%0.89 | 29.41%0.22 | 18.18%0.26 | 4.76%0.22 | 20.00%0.18 |
Dividend per share | 13.89%0.615 | 10.00%0.165 | 15.38%0.15 | 15.38%0.15 | 15.38%0.15 | 25.58%0.54 | 15.38%0.15 | 30.00%0.13 | 30.00%0.13 | 30.00%0.13 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |